Issue 2, 2017

Novel bivalent securinine mimetics as topoisomerase I inhibitors

Abstract

A series of novel bivalent securinine mimetics incorporating different linkers between C-15 and C-15′ were synthesized and their topoisomerase I (Topo I) inhibitory activities evaluated. It was thus revealed that mimetic R2 incorporating a rigid m-substituted benzene linker exhibits Topo I inhibitory activity three times that of parent securinine. Comprehensive structure–activity relationship analyses in combination with docking studies were used to rationalize the potent activity of these bivalent mimetics. Mechanistic studies served to confirm the deductions arising from docking studies that the active bivalent mimetics not only inhibited complexation between Topo I and DNA but also stabilized the Topo I–DNA complex itself.

Graphical abstract: Novel bivalent securinine mimetics as topoisomerase I inhibitors

Supplementary files

Article information

Article type
Research Article
Submitted
05 Nov 2016
Accepted
23 Dec 2016
First published
03 Jan 2017
This article is Open Access
Creative Commons BY license

Med. Chem. Commun., 2017,8, 320-328

Novel bivalent securinine mimetics as topoisomerase I inhibitors

W. Hou, H. Lin, Z. Wang, M. G. Banwell, T. Zeng, P. Sun, J. Lin and W. Chen, Med. Chem. Commun., 2017, 8, 320 DOI: 10.1039/C6MD00563B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements